Evidence map›Paper›PMID 27122127›Full record

ArticleOncology reports2016

Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells.

Min-Ho Han, Won Sup Lee, Arulkumar Nagappan, Hye Jung Kim, Cheol Park, Gi-Young Kim, Sang Hoon Hong, Nam Deuk Kim, Gonsup Kim, Chung Ho Ryu and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Article
  9. [Chinese herbal medicine Euphorbia esula extract induces apoptosis and inhibits the proliferation, migration and invasion of multidrug resistant gastric carcinoma cells].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2018
    Article
  10. Article
  11. Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Min-Ho HanNatural Products Research Team, National Marine Biodiversity Institute of Korea, Seocheon 325-902, Republic of Korea.
Won Sup LeeDepartment of Internal Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-702, Republic of Korea.
Arulkumar NagappanDepartment of Internal Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-702, Republic of Korea.
Hye Jung KimDepartment of Pharmacology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-702, Republic of Korea.
Cheol ParkDepartment of Molecular Biology, College of Natural Sciences and Human Ecology, Dongeui University, Busan 614-714, Republic of Korea.
Gi-Young KimDepartment of Marine Life Sciences, Jeju National University, Jeju 690-756, Republic of Korea.
Sang Hoon HongDepartment of Internal Medicine, Dongeui University College of Korean Medicine, Busan 614-052, Republic of Korea.
Nam Deuk KimDepartment of Pharmacy, College of Pharmacy, Pusan National University, Busan 609-735, Republic of Korea.
Gonsup KimSchool of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, Jinju 660-701, Republic of Korea.
Chung Ho RyuDivision of Applied Life Science (BK 21 Program), Research Institute of Life Science, Gyeongsang National University, Jinju 660-701, Republic of Korea.
Sung Chul ShinDepartment of Chemistry, Research Institute of Life Science, Gyeongsang National University, Jinju 660-701, Republic of Korea.
Yung Hyun ChoiDepartment of Biochemistry, Dongeui University College of Korean Medicine, Busan 614-052, Republic of Korea.
Gyeongsang National University · KRDong-Eui University · KRJeju National University · KRMarine Biodiversity Institute of Korea · KRPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Korean prostrate spurge Euphorbia supina (Euphorbiaceae family) has been used as a folk medicine in Korea against a variety of ailments such as bronchitis, hemorrhage, jaundice and multiple gastrointestinal diseases. Polyphenols from Korean E. supina (PES) which include quercetin and kaempferol derivatives have anticancer properties. Hence, we investigated the anticancer effects of PES on U937 human leukemic cells. Firstly, PES significantly inhibited the proliferation of U937 cells in a dose-dependent manner. PES induced accumulation of the sub-G1 DNA content (apoptotic cell population), apoptotic bodies and chromatin condensation and DNA fragmentation in the U937 cells. PES also induced activation of caspase-3, -8 and -9, subsequent cleavage of PARP, and significantly suppressed XIAP, cIAP-1 and cIAP-2 in a dose-dependent manner. Furthermore, PES activated Bid, and induced the loss of mitochondrial membrane potential (MMP, ΔΨm) along with upregulation of pro-apoptotic proteins (Bax and Bad), and downregulation of anti-apoptotic proteins (Bcl-2 and Bcl-xL) and cytochrome c release. The Fas receptor was upregulated by PES in a dose-dependent manner, suggesting that the extrinsic pathway was also involved in the PES-induced apoptosis. Moreover, the PES-induced apoptosis was at least in part associated with extracellular signal-regulated kinase (ERK) activation in the U937 human leukemic cells. This study provides evidence that PES may be useful in the treatment of leukemia.

Indexed as

Antineoplastic AgentsApoptosisBaculoviral IAP Repeat-Containing 3 Proteinbcl-2-Associated X Proteinbcl-Associated Death ProteinBH3 Interacting Domain Death Agonist ProteinCaspase 3Caspase 8Caspase 9Cell Line, TumorCell ProliferationCytochromes cDNA FragmentationEnzyme ActivationEuphorbiaExtracellular Signal-Regulated MAP KinasesAntineoplastic AgentsBaculoviral IAP Repeat-Containing 3 ProteinBAD protein, humanbcl-2-Associated X Proteinbcl-Associated Death ProteinBH3 Interacting Domain Death Agonist ProteinBID protein, humanBIRC3 protein, humanCaspase 3Caspase 8Caspase 9Cytochromes cExtracellular Signal-Regulated MAP KinasesInhibitor of Apoptosis ProteinsPhosphoinositide-3 Kinase InhibitorsPhytochemicalsPoly(ADP-ribose) PolymerasesPolyphenolsUbiquitin-Protein LigasesXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID27122127
PMCPMC4899010
OpenAlexW2344323124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.